DRD5P1: A Drug Target / Disease Biomarker (G1817)

Target Name: DRD5P1

NCBI ID: G1817

DRD5P1

Other Name(s): dopamine receptor D5 pseudogene 1 | Dopamine receptor D5 pseudogene 1

DRD5P1: A Drug Target / Disease Biomarker

DRD5P1, also known as GPR8581, is a G protein-coupled receptor located on the surface of various cell types in the body. It is a potential drug target and has been identified as a potential biomarker for various diseases, including cancer, neurodegenerative diseases, and psychiatric disorders.

DRD5P1 is a member of the G protein-coupled receptor family, which is a large family of transmembrane proteins that play a crucial role in cellular signaling. These receptors are involved in various physiological processes in the body, including sensory perception, neurotransmission, and hormone signaling.

DRD5P1 is a highly conserved protein with a calculated molecular weight of 116.1 kDa. It consists of an extracellular domain, a transmembrane region, and an intracellular domain. The extracellular domain is responsible for the protein's cell surface expression and consists of a N-terminal region that contains a signal transduction domain, a protein kinase-activating domain, and a C-terminal region that contains a leucine-rich repeat domain.

The transmembrane region is responsible for the protein's interaction with intracellular signaling molecules. It is composed of a variable region that contains a transmembrane segment and a cytoplasmic tail. The variable region is responsible for the protein's interaction with ligands and for the formation of the protein-ligand complex.

The intracellular domain is responsible for the protein's interaction with intracellular signaling molecules. It is composed of a variable region that contains a nucleotide-binding oligomerization domain (NBO), a protein-ligand interaction domain, and a C-terminal region that contains a catalytic domain.

DRD5P1 is a G protein-coupled receptor that is involved in various physiological processes in the body. It is expressed in various tissues and cells in the body, including the brain, spinal cord, and peripheral tissues. It is involved in the regulation of various physiological processes, including sensory perception, neurotransmission, and hormone signaling.

DRD5P1 has been identified as a potential drug target due to its involvement in various diseases. For example, DRD5P1 has been shown to be involved in the development and progression of neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease. It has also been shown to be involved in the regulation of pain perception and the modulation of anxiety and depression.

In addition to its potential clinical applications, DRD5P1 has also been identified as a potential biomarker for various diseases. For example, it has been shown to be involved in the regulation of neurodegenerative diseases, including Alzheimer's disease, and has been used as a biomarker for the diagnosis and progression of these diseases. It has also been shown to be involved in the regulation of pain perception and has been used as a biomarker for the assessment of pain intensity.

In conclusion, DRD5P1 is a G protein-coupled receptor that is involved in various physiological processes in the body. It is highly conserved and has been shown to be involved in the regulation of various diseases, including neurodegenerative diseases and psychiatric disorders. As a potential drug target and biomarker, DRD5P1 is a promising target for the development of new therapeutic agents for the treatment of these diseases.

Protein Name: Dopamine Receptor D5 Pseudogene 1

The "DRD5P1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about DRD5P1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets